Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8709429 Markers of acute myeloid leukemia stem cells

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ravindra Majeti0

Irving L. Weissman0

Date of Patent

April 29, 2014

0

Patent Application Number

137397880

Date Filed

January 11, 2013

0

Patent Citations Received

US Patent 12122832 TIM-3-targeting antibodies and uses thereof

0

US Patent 11773165 Markers of acute myeloid leukemia stem cells

US Patent 11780918 Markers of acute myeloid leukemia stem cells

US Patent 11827704 Antibody molecules to PD-1 and uses thereof

0

US Patent 12060420 Compositions and methods to enhance the immune system

0

US Patent 12091458 Humanized antibodies against c-Kit

0

US Patent 11708412 Methods for treating hematologic cancers

0

US Patent 11760800 Markers of acute myeloid leukemia stem cells

Patent Primary Examiner

0

Patent abstract

Markers of acute myeloid leukemia stem cells (AMLSC) are identified. The markers are differentially expressed in comparison with normal counterpart cells, and are useful as diagnostic and therapeutic targets.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8709429 Markers of acute myeloid leukemia stem cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool